“…Available preclinical and clinical data indicate that brofaromine is effective and well tolerated in patients suffering from major depression and anxiety disorders (260,261). RS-2232 (134) and its hydroxylated metabolite RS-8359 (135) also display reversible and selective MAO-A inhibition and are active as antidepressants in animal models (262,263). Recent examples of potent, reversible and highly selective MAO-B inhibitors include the imidazolyl derivative 136 (MAO-B, IC 50 ) 30 nM; MAO-A, IC 50 > 20 000 nM) (264).…”